- Report
- May 2026
- 482 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 198 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- February 2026
- 250 Pages
Global
From €3968EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €3968EUR$4,490USD£3,436GBP
- Report
- January 2026
- 60 Pages
Global
From €1105EUR$1,250USD£957GBP
- Report
- February 2026
- 141 Pages
Global
From €3534EUR$3,999USD£3,061GBP
- Report
- August 2025
- 150 Pages
Global
From €2967EUR$3,358USD£2,570GBP
€3491EUR$3,950USD£3,023GBP
- Report
- August 2025
- 150 Pages
Global
From €2967EUR$3,358USD£2,570GBP
€3491EUR$3,950USD£3,023GBP
- Report
- August 2025
- 150 Pages
Global
From €2967EUR$3,358USD£2,570GBP
€3491EUR$3,950USD£3,023GBP
- Report
- October 2025
- 91 Pages
Global
From €4286EUR$4,850USD£3,712GBP
- Report
- June 2025
- 120 Pages
United States
From €5258EUR$5,950USD£4,554GBP
- Report
- November 2023
- 30 Pages
Global
From €2872EUR$3,250USD£2,487GBP
- Report
- May 2025
- 112 Pages
Global
From €4197EUR$4,750USD£3,635GBP
- Report
- June 2024
- 140 Pages
Asia Pacific
From €3419EUR$3,869USD£2,961GBP
- Report
- October 2022
- 286 Pages
Global
From €2209EUR$2,500USD£1,913GBP
- Report
- October 2022
- 307 Pages
Global
From €2209EUR$2,500USD£1,913GBP
- Report
- October 2022
- 53 Pages
Global
From €3093EUR$3,500USD£2,679GBP
- Report
- September 2022
- 168 Pages
Global
From €3093EUR$3,500USD£2,679GBP
- Report
- January 2026
- 103 Pages
Global
From €3500EUR$4,243USD£3,137GBP
- Report
- October 2024
- 84 Pages
Global
From €3500EUR$4,243USD£3,137GBP

The Fusion Protein market is a subset of the Drug Discovery market, focusing on the development of fusion proteins for therapeutic use. Fusion proteins are created by combining two or more proteins, which can be used to increase the stability, solubility, and bioavailability of the proteins. Fusion proteins can also be used to target specific tissues or organs, or to increase the half-life of a protein.
Fusion proteins are used in a variety of therapeutic areas, including oncology, immunology, and metabolic diseases. They are also used in the development of vaccines and diagnostics.
Companies in the Fusion Protein market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more